Literature DB >> 4972271

An investigation of three patients with Christmas disease due to an abnormal type of factor IX.

K W Denson, R Biggs, P M Mannucci.   

Abstract

Three patients with Christmas disease whose plasma was shown to have a prolonged one-stage prothrombin time with ox brain thromboplastin have been investigated. These patients have an inhibitor for the reaction between factor X, factor VII, and ox brain extract. The abnormal constituent responsible for this inhibitor appears to be factor IX whuch is functionally inactive but antigenically indistinguishable from normal factor IX. It is proposed that patients might be classified into haemophilia B(+) for patients with this defect (Christmas disease(+)) and haemophilia B(-) (Christmas disease(-)) for patients who have classical Christmas disease.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4972271      PMCID: PMC473716          DOI: 10.1136/jcp.21.2.160

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  THE THROMBOTEST REAGENT AND CHRISTMAS DISEASE.

Authors:  P KIDD; K W DENSON; R BIGGS
Journal:  Lancet       Date:  1963-09-07       Impact factor: 79.321

2.  THROMBIN AND THE INTERACTION OF FACTORS 8 AND 9.

Authors:  R BIGGS; R G MACFARLANE; K W DENSON; B J ASH
Journal:  Br J Haematol       Date:  1965-05       Impact factor: 6.998

3.  Immunological investigation of a Christmas factor inhibitor by means of Boyden's technique.

Authors:  J COLOMBANI; E TERRIER
Journal:  Nature       Date:  1962-12-15       Impact factor: 49.962

4.  A naturally occurring inhibitor of Christmas factor (factor IX).

Authors:  R M HARDISTY
Journal:  Thromb Diath Haemorrh       Date:  1962-10-01

5.  Investigation of a haemorrhagic disease due to beta-prothromboplastin deficiency complicated by a specific inhibitor of thromboplastin formation.

Authors:  P FANTL; A G MARR; R J SAWERS
Journal:  Australas Ann Med       Date:  1956-08

6.  The coagulant action of Russell's viper venom; the use of antivenom in defining its reaction with a serum factor.

Authors:  R G MACFARLANE
Journal:  Br J Haematol       Date:  1961-10       Impact factor: 6.998

7.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

8.  Haemophilia Bm: a new type of factor-IX deficiency.

Authors:  C Hougie; J J Twomey
Journal:  Lancet       Date:  1967-04-01       Impact factor: 79.321

  8 in total
  16 in total

1.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

2.  Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.

Authors:  A Girolami; G Patrassi; A Burul
Journal:  Blut       Date:  1976-07

Review 3.  Hereditary disorders of blood coagulation due to defective and deficient synthesis of protein.

Authors:  D P Jackson
Journal:  Trans Am Clin Climatol Assoc       Date:  1971

4.  Hemophilia B+ or Bm. First case reported in Italy.

Authors:  A Girolami; G Cella; G Bareggi
Journal:  Blut       Date:  1973-04

5.  Molecular deficiencies of human blood coagulation.

Authors:  E A Beck
Journal:  Experientia       Date:  1972-01-15

6.  The genetic basis of variation in factor 8 levels among haemophiliacs.

Authors:  D F Roberts
Journal:  J Med Genet       Date:  1971-06       Impact factor: 6.318

7.  Polymorphism of normal factor IX detected by mouse monoclonal antibodies.

Authors:  A Wallmark; R Ljung; I M Nilsson; L Holmberg; U Hedner; M Lindvall; H O Sjögren
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  An immunological investigation of factor VIII associated antigen in combined factor V and factor VIII deficiency.

Authors:  A Girolami; N Borsato; G Patrassi; A Sticchi
Journal:  Blut       Date:  1976-08

9.  Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.

Authors:  A Girolami; R Dal Bo Zanon; L De Marco; G Cappellato
Journal:  Blut       Date:  1980-04

10.  Incidence, significance, and subtypes of hemophilia BM in a large population of hemophilia B patients.

Authors:  A Girolami; R Dal Bo Zanon; P Saltarin; V Quaino; G Altinier; T Ripa; A Marchetti; D Stocco
Journal:  Blut       Date:  1982-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.